These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2268007)

  • 21. Dose-response curves for four neuromuscular blockers using continuous i.v. infusion.
    Shanks CA; Walker JS; Ramzan MI; Triggs EJ
    Br J Anaesth; 1981 Jun; 53(6):627-33. PubMed ID: 7248126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response curves for alcuronium and pancuronium alone and in combination.
    Shanks CA
    Anaesth Intensive Care; 1982 Aug; 10(3):248-51. PubMed ID: 7125191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of thumb acceleration and thenar EMG in a pharmacodynamic study of alcuronium.
    Meretoja OA; Werner MU; Wirtavuori K; Luosto T
    Acta Anaesthesiol Scand; 1989 Oct; 33(7):545-8. PubMed ID: 2816236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed onset of alcuronium effect in children with cyanotic congenital heart disease.
    Keneally JP; Goonetilleke PH; Ramzan IM
    Anaesth Intensive Care; 1993 Apr; 21(2):197-200. PubMed ID: 8517511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluation of dosage and duration of action of d-tubocurarine in the pediatric age group.
    Goudsouzian NG; Donlon JV; Savarese JJ; Ryan JF
    Anesthesiology; 1975 Oct; 43(4):416-25. PubMed ID: 170845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metocurine in infants and children: neuromuscular and clinical effects.
    Goudsouzian NG; Liu LM; Savarese JJ
    Anesthesiology; 1978 Oct; 49(4):266-9. PubMed ID: 697081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia.
    Meretoja OA; Wirtavuori K; Neuvonen PJ
    Anesth Analg; 1988 Jan; 67(1):21-6. PubMed ID: 2892436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution, elimination, and action of d-tubocurarine in neonates, infants, children, and adults.
    Matteo RS; Lieberman IG; Salanitre E; McDaniel DD; Diaz J
    Anesth Analg; 1984 Sep; 63(9):799-804. PubMed ID: 6465573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of resting muscle tension on the dose-effect relationship of d-tubocurarine: does preload influence the evoked EMG?
    Kopman AF
    Anesthesiology; 1988 Dec; 69(6):1003-5. PubMed ID: 3195741
    [No Abstract]   [Full Text] [Related]  

  • 30. Relative potency of some neuromuscular blocking drugs in vivo and in vitro.
    Anttila P; Ertama P
    Med Biol; 1978 Jun; 56(3):152-5. PubMed ID: 682698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vecuronium and d-tubocurarine combination: potentiation of effect.
    Mirakhur RK; Gibson FM; Ferres CJ
    Anesth Analg; 1985 Jul; 64(7):711-4. PubMed ID: 2861763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical research of muscular relaxation induced by alcuronium and pancuronium].
    Gong Z; Ye T; Pei L; Luo X; Luo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):301-4. PubMed ID: 8575054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative potency and speed of onset of fazadinium and d-tubocurarine.
    Hussain SZ; Healy TE; Birmingham AT
    Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suxamethonium--electromyographic studies in children.
    Brown TC; Meretoja OA; Bell B; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):473-6. PubMed ID: 2268011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative cutaneous histamine release by neuromuscular blocking agents.
    Galletly DC
    Anaesth Intensive Care; 1986 Nov; 14(4):365-9. PubMed ID: 2436505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of muscle relaxants in clinical use.
    Ertama P; Mäkeläinen A
    Ann Chir Gynaecol; 1977; 66(2):113-9. PubMed ID: 141237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.
    Gibaldi M; Levy G; Hayton W
    Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414
    [No Abstract]   [Full Text] [Related]  

  • 40. [Atracurium--increased duration of its effect following alcuronium].
    Janda A; Mühlsteiger B; Schwarz S
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):203-5. PubMed ID: 2393076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.